Trials / Completed
CompletedNCT05140642
Safety and Efficacy Study of AI LVEF
Blinded Randomized Controlled Trial of Artificial Intelligence Guided Assessment of Cardiac Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,495 (actual)
- Sponsor
- Cedars-Sinai Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 110 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in preliminary readings of echocardiograms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Automated annotation of the left ventricle through deep learning | A semantic segmentation deep learning model will identify the left ventricle and label the left ventricle. The AI model will produce an assessment of LVEF using video based features. |
| OTHER | Sonographer Measurement of LVEF | Standard practice sonographer measurement of left ventricle and assessment of LVEF |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2022-06-29
- Completion
- 2022-06-29
- First posted
- 2021-12-01
- Last updated
- 2022-07-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05140642. Inclusion in this directory is not an endorsement.